Denali Therapeutics Inc. (DNLI) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 02/14/20
Has Denali Therapeutics (DNLI) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 02/07/20
Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 02/01/20
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/19
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s WebsiteGlobeNewsWire • 09/04/19
Denali Therapeutics: Key Catalysts Coming Up For This Neurodegenerative Disease PioneerSeeking Alpha • 06/12/19
Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/19
Analysts Estimate Denali Therapeutics Inc. (DNLI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/03/19